These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 25620068)
1. Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate. Rassu G; Soddu E; Cossu M; Brundu A; Cerri G; Marchetti N; Ferraro L; Regan RF; Giunchedi P; Gavini E; Dalpiaz A J Control Release; 2015 Mar; 201():68-77. PubMed ID: 25620068 [TBL] [Abstract][Full Text] [Related]
2. Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage. Farr AC; Xiong MP Mol Pharm; 2021 Feb; 18(2):593-609. PubMed ID: 32926630 [TBL] [Abstract][Full Text] [Related]
3. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin. Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924 [TBL] [Abstract][Full Text] [Related]
4. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles. Trotta V; Pavan B; Ferraro L; Beggiato S; Traini D; Des Reis LG; Scalia S; Dalpiaz A Eur J Pharm Biopharm; 2018 Jun; 127():250-259. PubMed ID: 29486302 [TBL] [Abstract][Full Text] [Related]
6. Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization. Lopedota A; Cutrignelli A; Laquintana V; Denora N; Iacobazzi RM; Perrone M; Fanizza E; Mastrodonato M; Mentino D; Lopalco A; Depalo N; Franco M Pharm Res; 2016 Sep; 33(9):2195-208. PubMed ID: 27245467 [TBL] [Abstract][Full Text] [Related]
7. Composite chitosan/alginate hydrogel for controlled release of deferoxamine: A system to potentially treat iron dysregulation diseases. Rassu G; Salis A; Porcu EP; Giunchedi P; Roldo M; Gavini E Carbohydr Polym; 2016 Jan; 136():1338-47. PubMed ID: 26572479 [TBL] [Abstract][Full Text] [Related]
8. In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates. Giuliani A; Balducci AG; Zironi E; Colombo G; Bortolotti F; Lorenzini L; Galligioni V; Pagliuca G; Scagliarini A; Calzà L; Sonvico F Drug Deliv; 2018 Nov; 25(1):376-387. PubMed ID: 29382237 [TBL] [Abstract][Full Text] [Related]
9. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies. Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983 [TBL] [Abstract][Full Text] [Related]
10. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats. Khan S; Patil K; Yeole P; Gaikwad R J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007 [TBL] [Abstract][Full Text] [Related]
11. The Role of Combined Penetration Enhancers in Nasal Microspheres on In Vivo Drug Bioavailability. Rassu G; Ferraro L; Pavan B; Giunchedi P; Gavini E; Dalpiaz A Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30373187 [TBL] [Abstract][Full Text] [Related]
12. Mucoadhesive microspheres for nasal administration of cyclodextrins. Gavini E; Rassu G; Haukvik T; Lanni C; Racchi M; Giunchedi P J Drug Target; 2009 Feb; 17(2):168-79. PubMed ID: 18985506 [TBL] [Abstract][Full Text] [Related]
13. Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats. Bshara H; Osman R; Mansour S; El-Shamy Ael-H Carbohydr Polym; 2014 Jan; 99():297-305. PubMed ID: 24274510 [TBL] [Abstract][Full Text] [Related]
14. Formulation and Evaluation of Neuroactive Drug Loaded Chitosan Nanoparticle for Nose to Brain Delivery: In-vitro Characterization and In-vivo Behavior Study. Qureshi M; Aqil M; Imam SS; Ahad A; Sultana Y Curr Drug Deliv; 2019; 16(2):123-135. PubMed ID: 30317997 [TBL] [Abstract][Full Text] [Related]
15. Nasal powders of quercetin-β-cyclodextrin derivatives complexes with mannitol/lecithin microparticles for Nose-to-Brain delivery: In vitro and ex vivo evaluation. Papakyriakopoulou P; Manta K; Kostantini C; Kikionis S; Banella S; Ioannou E; Christodoulou E; Rekkas DM; Dallas P; Vertzoni M; Valsami G; Colombo G Int J Pharm; 2021 Sep; 607():121016. PubMed ID: 34411652 [TBL] [Abstract][Full Text] [Related]
16. Brain uptake of an anti-ischemic agent by nasal administration of microparticles. Dalpiaz A; Gavini E; Colombo G; Russo P; Bortolotti F; Ferraro L; Tanganelli S; Scatturin A; Menegatti E; Giunchedi P J Pharm Sci; 2008 Nov; 97(11):4889-903. PubMed ID: 18300305 [TBL] [Abstract][Full Text] [Related]
17. Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting. Gavini E; Rassu G; Ferraro L; Beggiato S; Alhalaweh A; Velaga S; Marchetti N; Bandiera P; Giunchedi P; Dalpiaz A Eur J Pharm Biopharm; 2013 Feb; 83(2):174-83. PubMed ID: 23153670 [TBL] [Abstract][Full Text] [Related]
18. Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis. S V; A S; Annapoorna M; R J; Subramania I; Shantikumar V N; R J Colloids Surf B Biointerfaces; 2018 Jan; 161():129-138. PubMed ID: 29055865 [TBL] [Abstract][Full Text] [Related]
19. PLGA/DPPC/trimethylchitosan spray-dried microparticles for the nasal delivery of ropinirole hydrochloride: in vitro, ex vivo and cytocompatibility assessment. Karavasili C; Bouropoulos N; Sygellou L; Amanatiadou EP; Vizirianakis IS; Fatouros DG Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():1053-1062. PubMed ID: 26652464 [TBL] [Abstract][Full Text] [Related]
20. Carboxymethyl β-cyclodextrin grafted carboxymethyl chitosan hydrogel-based microparticles for oral insulin delivery. Yang Y; Liu Y; Chen S; Cheong KL; Teng B Carbohydr Polym; 2020 Oct; 246():116617. PubMed ID: 32747257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]